Nevan Elam is the founder of Rezolute. Rezolute has raised $312M in total funding. Latest round: Growth. Based in Redwood City, CA.
Nevan Elam is the founder of Rezolute, a clinical-stage biopharmaceutical company focused on therapies for metabolic diseases related to chronic glucose imbalance. He recently led Rezolute in a $90 million public offering to advance its clinical pipeline, which includes the investigational therapy RZ358 for congenital hyperinsulinism.
Full founder directory · Investor directory · Company funding database · Fundraising library